[1] Angus D C, Linde-Zwirble W T, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care[J]. Crit Care Med, 2001,29(7):1303-1310.
[2] Chapman M J, Nguyen N Q, Deane A M. Gastrointestinal dysmotility: clinical consequences and management of the critically ill patient[J]. Gastroenterol Clin North Am, 2011,40(4):725-739.
[3] Deitch E A. Gut-origin sepsis: evolution of a concept[J]. Surgeon, 2012,10(6):350-356.
[4] Sanders K M, Koh S D, Ward S M. Interstitial cells of cajal as pacemakers in the gastrointestinal tract[J]. Annu Rev Physiol, 2006,68:307-343.
[5] Eshraghian A, Eshraghian H. Interstitial cells of Cajal: a novel hypothesis for the pathophysiology of irritable bowel syndrome[J]. Can J Gastroenterol, 2011,25(5):277-279.
[6] Forster J, Damjanov I, Lin Z, et al. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings[J]. J Gastrointest Surg, 2005,9(1):102-108.
[7] 杨铁城,张淑文,王红,等.脓毒症大鼠小肠动力障碍及厚朴酚干预实验研究[J].首都医科大学学报,2009,30(6):849-853.
[8] Zhang W W, Li Y, Wang X Q, et al. Effects of magnolol and honokiol derived from traditional Chinese herbal remedies on gastrointestinal movement[J]. World J Gastroenterol, 2005,11(28):4414-4418.
[9] Jeong S I, Kim Y S, Lee M Y, et al. Regulation of contractile activity by magnolol in the rat isolated gastrointestinal tracts[J]. Pharmacol Res, 2009,59(3):183-188.
[10] Lim H C, Lee S I, Chen J Dz, et al. Electrogastrography associated with symptomatic changes after prokinetic drug treatment for functional dyspepsia[J]. World J Gastroenterol, 2012,18(41):5948-5956.
[11] Shen J L, Man K M, Huang P H, et al. Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders[J]. Molecules, 2010,15(9):6452-6465.
[12] Zarate N, Mearin F, Wang X Y, et al. Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management[J]. Gut, 2003,52(7):966-970.
[13] Feldstein A E, Miller S M, El-Youssef M, et al. Chronic intestinal pseudoobstruction associated with altered interstitial cells of cajal networks[J]. J Pediatr Gastroenterol Nutr, 2003,36(4):492-497.
[14] Zhao C, Liu Z Q. Comparison of antioxidant abilities of magnolol and honokiol to scavenge radicals and to protect DNA[J]. Biochimie, 2011,93(10):1755-1760.
[15] Yunhe F, Bo L, Xiaosheng F, et al. The effect of magnolol on the Toll-like receptor 4/nuclear factor kappa B signaling pathway in lipopolysaccharide-induced acute lung injury in mice[J]. Eur J Pharmacol, 2012,689(13):255-261.
[16] de Winter B Y, van Nassauw L, de Man J G, et al. Role of oxidative stress in the pathogenesis of septic ileus in mice[J]. Neurogastroenterol Motil, 2005,17(2):251-261.
[17] Torihashi S, Ozaki H, Hori M, et al. Resident macrophages activated by lipopolysaccharide suppress muscle tension and initiate inflammatory response in the gastrointestinal muscle layer[J]. Histochem Cell Biol, 2000,113(2):73-80.
[18] Lodato R F, Khan A R, Zembowicz M J, et al. Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide[J]. Am J Physiol, 1999,276(6 Pt 1):G1356-1362.
[19] Beckett E A, Ro S, Bayguinov Y, et al. Kit signaling is essential for development and maintenance of interstitial cells of Cajal and electrical rhythmicity in the embryonic gastrointestinal tract[J]. Dev Dyn, 2007,236(1):60-72.
[20] Roskoski R, Jr. Signaling by Kit protein-tyrosine kinase the stem cell factor receptor[J]. Biochem Biophys Res Commun, 2005,337(1):1-13.
[21] Horvath V J, Vittal H, Lorincz A, et al. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis[J]. Gastroenterology, 2006,130(3):759-770.
[22] Gonzalo S, Grasa L, Arruebo M P, et al. Lipopolysaccharide-induced intestinal motility disturbances are mediated by c-Jun NH2-terminal kinases[J]. Dig Liver Dis, 2011,43(4):277-285.
[23] 韩韩璐,马涛,胡文全,等.脓毒症的免疫损伤[J].中国煤炭工业医学杂志,2012,15(6):890-892. |